The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update to Fundraise Timetable

5 Jul 2023 11:30

RNS Number : 0692F
WANdisco Plc
05 July 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

5 July 2023

WANdisco plc

 

Update to Fundraise Timetable

 

Further to the announcement of 4 July 2023, WANdisco plc (the "Company" and together with its subsidiaries, "WANdisco" or the "Group") (LSE: WAND), the data activation platform, hereby provides an update on the timetable associated with its $30 million fundraise.

In working to complete the fundraise process, the Company has encountered the requirement under Jersey law to seek further shareholder approval to increase its authorised share capital in order to issue the Offer Shares pursuant to the Fundraise. Completion of this step, as explained below, means settlement of the Fundraise and Admission are now expected to take place on 25 July 2023, subject to the passing of the necessary resolution by shareholders.

Requirement for General Meeting

Under the Company's Memorandum and pursuant to the Companies (Jersey) Law 1991 as amended, the authorised share capital of the company is £10,000,000 divided into 100,000,000 Ordinary Shares of £0.10 each. Following the Fundraise the Company's enlarged issued ordinary share capital would amount to 114,725,069 Ordinary Shares. If all Offer Shares were issued, this would exceed the Company's authorised share capital by 14,725,069 Ordinary Shares, rendering those excess Ordinary Shares invalid.

Consequently, the Company proposes to increase its authorised share capital limit set out in its Memorandum from £10,000,000 divided into 100,000,000 Ordinary Shares of £0.10 each to £30,000,000 divided into 300,000,000 Ordinary Shares of £0.10 each. The Company will convene a general meeting for 10.00 a.m. on 24 July 2023 ("General Meeting") at which a special resolution to effect the required increase to the Company's authorised share capital and amend its Memorandum will be proposed (the "Resolution"). The Company's existing shareholder authorities do not provide the directors of the Company with sufficient power to allot and issue all the newly authorised Ordinary Shares. A Notice of General Meeting will be posted to shareholders later today.

Amendment to Placing Agreement

Placees are advised that the Joint Bookrunners and the Company have today amended the Placing Agreement to extend the long-stop date for completion of the Placing from 14 July 2023 to 31 July 2023 and to add further conditions under the Placing Agreement, including that the Resolution is passed. The Fundraise, which is not underwritten, remains conditional on, among other things, the publication of the Company's FY 2022 audited report and accounts and the lifting of the suspension of the Ordinary Shares to trading on AIM. The updated anticipated timetable for the Fundraise is set out below.

Save where changes to the Terms of Placing (set out in Appendix 1 of the Launch Announcement of 3 July 2023) are required to reflect the new timetable below, all other terms and conditions of the Placing remain the same including that the Fundraise remains conditional on, among other things, the lifting of the Suspension.

The Joint Bookrunners will communicate with all Placees immediately following this announcement. The Company shall also be communicating with the Direct Subscribers.

FY Audited Results

In the coming days, the Company expects to publish its audited FY22 audited financial results on a going concern basis subject to the successful completion of the Fundraise.

 

Updated Timetable for the Fundraise

 

Notice of General Meeting published 5 July 2023

 

General Meeting 10.00 a.m. on 24 July 2023

 

Suspension lifted on Ordinary Shares 7.30 a.m. on 25 July 2023

 

Admission and commencement of dealing in the Offer Shares 8.00 a.m. on or around 25 July 2023

 

CREST accounts to be credited with Offer Shares 8.00 a.m. on or around 25 July 2023

 

Each of the times and dates in this announcement refer to London time and are subject to change. Any such change will be notified to Shareholders by an announcement on a Regulatory Information Service.

Capitalised terms used but not defined in this announcement shall have the meaning given to them in the Company's Launch Announcement of 3 July 2023, unless context provides otherwise.

This Announcement is released by WANdisco plc and contains inside information for the purposes of Article 7 of the UK Market Abuse Regulation and is disclosed in accordance with the Company's obligations under Article 17 of the UK Market Abuse Regulation.

 

The person responsible for arranging the release of this announcement on behalf of WANdisco plc is Larry Webster, Company Secretary.

 

For further information, please contact:

 

FTI Consulting

Matt Dixon / Rob Mindell / Kwaku Aning

+44 (0)20 3727 1137

Stifel (Nomad and Joint Broker)

Fred Walsh / Richard Short / Tom Marsh

+44 (0)20 7710 7600

Liberum (Joint Broker)

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

+44 (0)20 3100 2000

 

 

IMPORTANT INFORMATION

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, TRANSMISSION, FORWARDING OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (COLLECTIVELY, THE "UNITED STATES"), AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

 This announcement or any part of it does not constitute or form part of any offer to issue or sell, or the solicitation of an offer to acquire, purchase or subscribe for, any securities in the United States, Canada, Australia, Japan or the Republic of South Africa or any other jurisdiction in which the same would be unlawful. No public offering of the Placing Shares is being made in any such jurisdiction.

No action has been taken by the Company, the Joint Bookrunners or any of their respective affiliates, or any person acting on its or their behalf that would permit an offer of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such Placing Shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company, the Joint Bookrunners to inform themselves about, and to observe, such restrictions.

No prospectus, offering memorandum, offering document or admission document has been or will be made available in connection with the matters contained in this announcement and no such prospectus is required (in accordance with Regulation (EU) No 2017/1129 (as amended) (the "EU Prospectus Regulation") or the EU Prospectus Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "UK Prospectus Regulation")) to be published. Persons needing advice should consult a qualified independent legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

 The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and may not be offered, sold or transferred, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with the securities laws of any State or any other jurisdiction of the United States. Accordingly, the Placing Shares will be offered and sold only (i) outside of the United States in "offshore transactions" (as such term is defined in Regulation S under the Securities Act ("Regulation S")) pursuant to Regulation S and otherwise in accordance with applicable laws; and (ii) in the United States to persons who are "qualified institutional buyers" (as defined in Rule 144A under the Securities Act) ("QIBs") and who have executed and delivered to the Company and the Joint Bookrunners a US investor letter substantially in the form provided to it, in each case, pursuant to an exemption from, or in a transaction not subject to, registration under the Securities Act. No public offering of the Securities will be made in the United States or elsewhere.

The Placing has not been approved or disapproved by the US Securities and Exchange Commission, any state securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the Placing, or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States.

This announcement has not been approved by the London Stock Exchange.

Members of the public are not eligible to take part in the Placing. This announcement is directed at and is only being distributed to: (a) if in a member state of the European Economic Area (the "EEA"), qualified investors ("Qualified Investors") within the meaning of Article 2(e) of the EU Prospectus Regulation; (b) if in the United Kingdom, qualified investors within the meaning of Article 2(e) of the UK Prospectus Regulation who are also (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professional" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (ii) high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2)(a) to (d) of the Order ("UK Qualified Investors"); or (c) other persons to whom it may otherwise be lawfully communicated (all such persons together being "Relevant Persons").

 This announcement must not be acted on or relied on by persons who are not Relevant Persons. Persons distributing this announcement must satisfy themselves that it is lawful to do so. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.

The relevant clearances have not been, nor will they be, obtained from the securities commission of any province or territory of Canada, no prospectus has been lodged with, or registered by, the Australian Securities and Investments Commission or the Japanese Ministry of Finance; the relevant clearances have not been, and will not be, obtained for the South Africa Reserve Bank or any other applicable body in the Republic of South Africa in relation to the Placing Shares and the Placing Shares have not been, nor will they be, registered under or offered in compliance with the securities laws of any state, province or territory of Australia, Canada, Japan or the Republic of South Africa. Accordingly, the Placing Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction in which such activities would be unlawful.

Certain statements contained in this announcement constitute "forward-looking statements" with respect to the financial condition, results of operations and businesses and plans of the Company and the Group. Words such as "believes", "anticipates", "estimates", "expects", "intends", "plans", "aims", "potential", "will", "would", "could", "considered", "likely", "estimate" and variations of these words and similar future or conditional expressions, are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon future circumstances that have not occurred. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward-looking statements and forecasts. As a result, the Group's actual financial condition, results of operations and business and plans may differ materially from the plans, goals and expectations expressed or implied by these forward-looking statements. No representation or warranty is made as to the achievement or reasonableness of, and no reliance should be placed on, such forward-looking statements. The forward-looking statements contained in this announcement speak only as of the date of this announcement. The Company, its directors, the Joint Bookrunners, their respective affiliates and any person acting on its or their behalf each expressly disclaim any obligation or undertaking to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required to do so by applicable law or regulation, the FCA or the London Stock Exchange.

Each Joint Bookrunner is authorised and regulated in the United Kingdom by the FCA. Each Joint Bookrunner acting exclusively for the Company and no one else in connection with the Placing, the contents of this announcement or any other matters described in this announcement. Neither Joint Bookrunner will regard any other person as its client in relation to the Placing, the content of this announcement or any other matters described in this announcement and will not be responsible to anyone (including any Placees) other than the Company for providing the protections afforded to its clients or for providing advice to any other person in relation to the Placing, the content of this announcement or any other matters referred to in this announcement.

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by either Joint Bookrunner or by any of its affiliates or any person acting on its or their behalf as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

This announcement does not constitute a recommendation concerning any investor's investment decision with respect to the Placing. Any indication in this announcement of the price at which ordinary shares have been bought or sold in the past cannot be relied upon as a guide to future performance. The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance. This announcement does not identify or suggest, or purport to identify or suggest, the risks (direct or indirect) that may be associated with an investment in the Placing Shares. The contents of this announcement are not to be construed as legal, business, financial or tax advice. Each investor or prospective investor should consult their or its own legal adviser, business adviser, financial adviser or tax adviser for legal, financial, business or tax advice.

No statement in this announcement is intended to be a profit forecast or profit estimate for any period, and no statement in this announcement should be interpreted to mean that earnings, earnings per share or income, cash flow from operations or free cash flow for the Company for the current or future financial years would necessarily match or exceed the historical published earnings, earnings per share or income, cash flow from operations or free cash flow for the Company.

All offers of the Placing Shares will be made pursuant to an exemption under the UK Prospectus Regulation or the EU Prospectus Regulation from the requirement to produce a prospectus. This announcement is being distributed and communicated to persons in the UK only in circumstances to which section 21(1) of the Financial Services and Markets Act, 2000, as amended does not apply.

The Placing Shares to be issued or sold pursuant to the Placing will not be admitted to trading on any stock exchange other than the London Stock Exchange.

 Persons (including, without limitation, nominees and trustees) who have a contractual or other legal obligation to forward a copy of this announcement should seek appropriate advice before taking any action.

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

This announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside the United Kingdom.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVRRROKUBRAR
Date   Source Headline
27th Apr 201711:45 amRNSDirector Dealing
24th Apr 20177:00 amRNSSignificant customer win and Q1 update
21st Apr 20177:00 amRNSPosting of Annual Report and Notice of AGM
5th Apr 20177:00 amRNSTotal Voting Rights
29th Mar 20177:00 amRNSLong Term Incentive Plan
28th Mar 20177:00 amRNSLaunch of WANdisco Fusion 2.10
8th Mar 20177:00 amRNSPreliminary Results
6th Mar 20174:40 pmRNSSecond Price Monitoring Extn
6th Mar 20174:35 pmRNSPrice Monitoring Extension
23rd Feb 20177:00 amRNSBoard Update
14th Feb 20177:00 amRNSNotice of Results and Investor Presentation
18th Jan 20174:40 pmRNSSecond Price Monitoring Extn
18th Jan 20174:35 pmRNSPrice Monitoring Extension
16th Jan 20177:00 amRNSTrading Update
30th Dec 20167:00 amRNSTotal Voting Rights
29th Dec 20166:00 pmRNSDirector Dealings
23rd Dec 20167:00 amRNSDirector Dealing
21st Dec 20163:00 pmRNSHolding(s) in Company
19th Dec 20167:01 amRNSSignificant customer win
19th Dec 20167:00 amRNSAppointment of Nomad and Joint Broker
8th Dec 20163:15 pmRNSListing Application
8th Dec 20167:00 amRNSGrant of Share Options to Executive Directors
8th Dec 20167:00 amRNSDirector/PDMR Shareholding
5th Dec 20167:00 amRNSBoard Appointments
2nd Dec 20164:06 pmRNSHolding(s) in Company
1st Dec 20167:46 amRNSTotal Voting Rights
15th Nov 20167:00 amRNSContract win
1st Nov 20167:00 amRNSTotal Voting Rights
10th Oct 20167:00 amRNSWANdisco secures two new record contracts
10th Oct 20167:00 amRNSAppointments
6th Oct 20167:01 amRNSRe-instatement of David Richards
6th Oct 20167:00 amRNSDirectorate Changes
30th Sep 20162:24 pmRNSTotal Voting Rights
29th Sep 201610:41 amRNSDirectorate Change
29th Sep 201610:30 amRNSDirectorate Change
28th Sep 20167:00 amRNSAppointment of Chief Financial Officer
1st Sep 20167:00 amRNSTotal Voting Rights
5th Aug 20167:35 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Aug 20167:00 amRNSInterim Results
1st Aug 20169:02 amRNSTotal Voting Rights
13th Jul 20163:06 pmRNSHolding(s) in Company
12th Jul 201610:11 amRNSHolding(s) in Company
8th Jul 20166:10 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
6th Jul 20168:00 amRNSDirectors Holdings and Total Voting Rights
5th Jul 201611:05 amRNSResult of General Meeting
1st Jul 20167:01 amRNSBlock Listing Interim Return
1st Jul 20167:00 amRNSTotal Voting Rights
29th Jun 20167:00 amRNSPatent update
27th Jun 20167:00 amRNSUpdate on WANdisco OEM sales partnership with IBM
10th Jun 20167:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.